星宇控股(02346.HK)拟配售最多1亿股 筹资3600万港元
格隆汇3月24日丨星宇控股(02346.HK)发布公告,于2021年3月24日,公司配售股份将根据于股东周年大会上授予董事的一般授权配发及发行,跟配售代理中国北方证券集团订立配售协议。据此,北证同意以个别基准,按竭尽所能基准以每股0.37港元的价格配售最多1亿股配售股份。配售价为每股股份0.37港元。
预期配售事项所得款项净额约为3,600万港元。公司拟动用配售事项所得款项净额在出现机会时用于业务发展或投资,以及作为运营资金与集团一般用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.